Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Balancing safety and access in Oregon’s psilocybin servicesInternational Journal of Drug Policy · 2026-06-12Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-07C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine · 2026-04-30356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-04-24Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2026-04-18A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-13Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-09Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical ImplicationsFOCUS The Journal of Lifelong Learning in Psychiatry · 2026-03-31Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-29Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)Brain Sciences · 2026-03-25The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22A fungus among us: investigating queensland’s largest magic mushroom growing operationAustralian Journal of Forensic Sciences · 2026-03-15A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-03-12Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-08Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological AnalysisQualitative Health Research · 2026-02-16Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-02-11The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidenceZenodo (CERN European Organization for Nuclear Research) · 2026-01-25Effects of psilocybin and chronic mild stress on microglial activation in rat spinal cord: an ex vivo analysisPharmacological Reports · 2026-01-19Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological AnalysisResearch Explorer (The University of Manchester) · 2026-01-08The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measuresJournal of Psychopharmacology · 2025-12-31Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 StudyPsychedelic Medicine · 2025-12-22Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatmentEClinicalMedicine · 2025-11-30Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trialProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-11-21Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.Unknown journal · 2025-11-06Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocinMetabolic Engineering · 2025-11-04Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreatFrontiers in Psychiatry · 2025-08-05Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot studyJournal of Vision · 2025-07-14Psilocybin treatment extends cellular lifespan and improves survival of aged micenpj Aging · 2025-07-07Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyComprehensive Psychiatry · 2025-07-01Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-06-30Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depressionJournal of Psychopharmacology · 2025-06-30Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot studyJournal of Affective Disorders · 2025-06-08Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamusJournal of Psychopharmacology · 2025-04-16Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.Unknown journal · 2025-04-14595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-08Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trialNeuropsychopharmacology · 2025-04-08Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-03-31Pharmacokinetics of Psilocybin: A Systematic Review.Unknown journal · 2025-03-24Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24Risks of using psilocybin in treatment of treatment-resistant depressionJournal of Education Health and Sport · 2025-03-05Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02Psychedelics and Suicide-Related Outcomes: A Systematic Review.Unknown journal · 2025-02-19Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’Cureus · 2025-01-28Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trialPLoS ONE · 2025-01-16Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health ConditionsAmerican Journal of Psychiatry · 2024-12-31Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ ConcernsThe Journal of Law Medicine & Ethics · 2024-12-31The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Psilocybin increases emotional empathy in patients with major depressionMolecular Psychiatry · 2024-12-17Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine useFrontiers in Psychiatry · 2024-12-05Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II DisorderPsychedelic Medicine · 2024-11-17Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) TrialCanadian Journal of Pain · 2024-11-07Amid magic and menace: psychiatrists’ attitudes to psilocybin therapyIrish Journal of Psychological Medicine · 2024-11-06Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trialJournal of Vision · 2024-11-04Optimized psilocybin production in tryptophan catabolism-repressed fungiMicrobial Biotechnology · 2024-10-31“The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybinJournal of Psychedelic Studies · 2024-10-28Impact of psilocybin on cognitive function: A systematic review.Unknown journal · 2024-09-30Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot studyJournal of Affective Disorders · 2024-09-26Quantitative LC-QToF-MS Analysis of Mycochemicals in Amanita muscaria, Psilocybe spp. (Agaricomycetes), and Consumer ProductsInternational journal of medicinal mushrooms · 2024-09-19Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”Frontiers in Psychiatry · 2024-06-03THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31The influence of psilocybin on subconscious and conscious emotional learningiScience · 2024-05-18The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybinBMC Psychiatry · 2024-04-24A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomesJournal of Psychedelic Studies · 2024-04-04Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022Drug and Alcohol Dependence · 2024-02-05Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based surveyPalliative Medicine · 2024-01-21A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.Unknown journal · 2024-01-17Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of PsilocybinBiological Psychiatry · 2024-01-04Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patientsNeuroscience Applied · 2023-12-31Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapyNeuroscience Applied · 2023-12-31Amygdala response to emotional faces following acute administration of psilocybin in healthy individualsNeuroscience Applied · 2023-12-29Investigation of the structure, stability, and relative solubility of psilocybin in water and pure organic solvents: A molecular simulation studyJournal of Molecular Liquids · 2023-11-06Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differencesScientific Reports · 2023-10-13CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANSIBRO Neuroscience Reports · 2023-09-30Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in ratsMolecular Psychiatry · 2023-08-31Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medicationNeuropsychopharmacology · 2023-07-12Must Psilocybin Always “Assist Psychotherapy”?American Journal of Psychiatry · 2023-07-11Psilocybin decelerates cellular senescenceResearch Square · 2023-06-26Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.Psychology of Addictive Behaviors · 2023-06-04Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic modelPsychological Medicine · 2023-06-01Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02In Search of: A Federal Safe Harbor for State Legalization of PsilocybinUnknown journal · 2022-12-31Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2022-12-31Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids.International Journal of Molecular Sciences · 2022-11-14Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Interplay of hydrogen bonding in deciding the conformers of psilocin: Computational insightsAuthorea Preprints · 2022-08-31Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of Personalized Medicine · 2022-06-18Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).PLoS ONE · 2022-03-15The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03Effects of psilocybin in relative and global cerebral blood flow and behavioural correlatesNeuroscience Applied · 2021-12-31Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorderNeuroscience Applied · 2021-12-31Unravelling a New Conformer of Psilocin Through Computational MethodsSSRN Electronic Journal · 2021-12-31Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.Journal of Psychopharmacology · 2021-12-16Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.Cerebral Cortex · 2021-10-31Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.Irish Journal of Medical Science (1971 -) · 2021-06-14Registered clinical studies investigating psychedelic drugs for psychiatric disorders.Unknown journal · 2021-05-17Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.Psychopharmacology · 2021-04-29Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-ProcessingBiological Psychiatry · 2021-04-26Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensisDrug Testing and Analysis · 2020-10-28P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlapHuman Brain Mapping · 2020-08-20Scoping Review Protocol: Mapping Psilocybin Animal ResearchUnknown journal · 2020-05-19Binding Interactions of Psilocin and Serotonin in the 5-HT2A ReceptorVTechWorks (Virginia Tech) · 2020-05-04Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary ElectrophoresisMolecules · 2020-03-28Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin ExperienceBiomedicines · 2020-02-17Psilocybin Induces Time-Dependent Changes in Global Functional ConnectivityBiological Psychiatry · 2020-01-12Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancerJournal of Psychopharmacology · 2020-01-08Psilocybin's effects on the brain and implications for depression treatmentEpubl LTU · 2019-12-31Psilocybin-Assisted Therapy: A Double-Blind Randomized Controlled TrialUnknown journal · 2018-12-31Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot studyZurich Open Repository and Archive (University of Zurich) · 2018-12-31Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.European Neuropsychopharmacology · 2018-04-24LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in Pharmacology · 2017-11-07Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of Psychopharmacology · 2017-10-10Effect of Psilocybin on Empathy and Moral Decision-Making.The International Journal of Neuropsychopharmacology · 2017-08-31Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.NeuroImage · 2017-07-11Simultaneous determination of γ-hydroxybutyric acid, ibotenic acid and psilocybin in saliva samples by capillary electrophoresis coupled with a contactless conductivity detectorAnalytical Methods · 2016-12-31Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination taskEuropean Neuropsychopharmacology · 2016-09-30Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of Psychopharmacology · 2016-08-29Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans.Frontiers in Psychology · 2016-05-18Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences · 2016-04-17Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.European Neuropsychopharmacology · 2016-01-21P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteersEuropean Neuropsychopharmacology · 2015-08-31The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.NeuroImage Clinical · 2015-08-21PENGARUH PEMBERIAN EKSTRAK JAMUR PSILOCYBE CUBENSIS DOSIS BERTINGKAT TERHADAP RASA INGIN TAHU MENCIT SWISS WEBSTER YANG DIUKUR DENGAN MANUAL HOLE BOARDNeliti · 2014-12-31Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-15The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-15Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats.Biological and Pharmaceutical Bulletin · 2014-10-23P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI studyEuropean Neuropsychopharmacology · 2014-09-24Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybinDrug and Alcohol Dependence · 2014-06-06Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Biological Psychiatry · 2014-04-25[Suicide under the influence of "magic mushrooms"].PubMed · 2013-04-30Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.Journal for the Scientific Study of Religion · 2012-11-30Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.Journal of Psychopharmacology · 2011-09-27Voice of the psychonauts: coping, life purpose, and spirituality in psychedelic drug users.Journal of Psychoactive Drugs · 2011-06-30Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.Unknown journal · 2007-09-13Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” userForensic Toxicology · 2006-06-30Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples.Journal of Forensic Sciences · 2005-02-28Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples.Journal of forensic sciences · 2005-02-28Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection.Unknown journal · 2005-01-05Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometryAnalytica Chimica Acta · 2004-11-30Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples.Unknown journal · 2003-10-31